scholarly journals Increased extracellular volume in asymptomatic cocaine abusers detected by cardiovascular magnetic resonance imaging

2013 ◽  
Vol 15 (S1) ◽  
Author(s):  
Ulf K Radunski ◽  
Ulrike Fuger ◽  
Jens Reimer ◽  
Gunnar Lund ◽  
Gerhard Adam ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Cardiovascular Magnetic Resonance ◽  
Magnetic Resonance ◽  
Cardiovascular Magnetic Resonance Imaging ◽  
Extracellular Volume ◽  
Resonance Imaging

Contemporary Application of Cardiovascular Magnetic Resonance Imaging

2020 ◽  
Vol 71 (1) ◽  
pp. 221-234
Author(s):  
Yuchi Han ◽  
Yucheng Chen ◽  
Victor A. Ferrari
Keyword(s):  
Magnetic Resonance Imaging ◽  
Cardiovascular Magnetic Resonance ◽  
Heart Disease ◽  
Magnetic Resonance ◽  
Cardiovascular Magnetic Resonance Imaging ◽  
Volume Fraction ◽  
Imaging Modality ◽  
Myocardial Strain ◽  
Extracellular Volume ◽  
Resonance Imaging

Cardiovascular magnetic resonance imaging (CMR) is a comprehensive and versatile diagnostic and prognostic imaging modality that plays an increasingly important role in management of patients with cardiovascular disease. In this review, we discuss CMR applications in nonischemic cardiomyopathy, ischemic heart disease, arrhythmias, right ventricular diseases, and valvular heart disease. We emphasize the quantitative nature of CMR in current practice, from volumes, function, myocardial strain analysis, and late gadolinium enhancement to parametric mapping, including T1, T2, and T2* relaxation times and extracellular volume fraction assessment.

scholarly journals The Evolving Role of Cardiovascular Magnetic Resonance Imaging in the Evaluation of Systemic Amyloidosis

2019 ◽  
Vol 12 ◽  
pp. 1178623X1984351 ◽  
Author(s):  
Sanjay M Banypersad
Keyword(s):  
Magnetic Resonance Imaging ◽  
Cardiovascular Magnetic Resonance ◽  
Magnetic Resonance ◽  
Cardiovascular Magnetic Resonance Imaging ◽  
T2 Mapping ◽  
Extracellular Volume ◽  
Systemic Amyloidosis ◽  
Response To Treatment ◽  
Resonance Imaging ◽  
The Impact

Systemic amyloidosis is a serious multiorgan disease with reduced life expectancy, irrespective of type. The impact of magnetic resonance imaging (MRI) in managing this condition has been immense. The last decade in particular has seen a surge of interest in the assessment and evaluation of the heart in patients with systemic amyloidosis by cardiovascular magnetic resonance imaging (CMR), with approximately 85% of all publications on this subject arising in the last 10 years. This has been largely driven by the creation of new sequences and their subsequent modernisation and technical development, thereby rendering previously prohibitive methods clinically more relevant and applicable. In turn, this has led to an increased awareness and recognition of the disease. This review demonstrates how MRI has become a pivotal diagnostic tool in the assessment of cardiac amyloidosis over the last 2 decades, with the ability to track disease and predict mortality. Several different pathognomonic patterns of late gadolinium enhancement (LGE) are now recognised and are able to prognosticate. T1 mapping and extracellular volume (ECV) techniques have resulted in even earlier disease detection before LGE is even visible and along with T2 mapping, provide new insights into biology. As newer therapies also evolve and become available, the need for accurate tracking of cardiac disease response to treatment carries increasing importance. All these are examined in this review, mainly focussing on light-chain (AL) and transthyretin (ATTR) amyloidosis.

Sign in / Sign up

Export Citation Format

Share Document